Moreover, acquired and inherited resistance of cancer cells were reported to be also mediated by altered molecular mechanisms and activated signaling pathways, such as the protein kinase B/mammalian target of rapamycin (Akt/mTOR) which is also implicated in Cisplatin resistance in human ovarian cancer cells [6]. Here, AKT1 is linked to cancer.